Latest BRAIDWELL LP Stock Portfolio
BRAIDWELL LP Performance:
2025 Q4: 11.18%YTD: 5.32%2024: -10.2%
Performance for 2025 Q4 is 11.18%, and YTD is 5.32%, and 2024 is -10.2%.
About BRAIDWELL LP and 13F Hedge Fund Stock Holdings
On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, BRAIDWELL LP reported an equity portfolio of $3.1 Billions as of 31 Dec, 2025.
The top stock holdings of BRAIDWELL LP are , EWTX, NBIX. The fund has invested 6.7% of it's portfolio in CARIS LIFE SCIENCES INC and 4.1% of portfolio in EDGEWISE THERAPEUTICS INC.
The fund managers got completely rid off GLOBUS MED INC (GMED), TENET HEALTHCARE CORP (THC) and EXACT SCIENCES CORP (EXAS) stocks. They significantly reduced their stock positions in ORUKA THERAPEUTICS INC, CASTLE BIOSCIENCES INC (CSTL) and XENCOR INC (XNCR). BRAIDWELL LP opened new stock positions in KODIAK SCIENCES INC (KOD), CENTESSA PHARMACEUTICALS PLC (CNTA) and BRIGHTSPRING HEALTH SVCS INC. The fund showed a lot of confidence in some stocks as they added substantially to FULCRUM THERAPEUTICS INC (FULC), SURROZEN INC (SRZN) and CELLDEX THERAPEUTICS INC NEW (CLDX).
The top stock holdings of BRAIDWELL LP are , EWTX, NBIX. The fund has invested 6.7% of it's portfolio in CARIS LIFE SCIENCES INC and 4.1% of portfolio in EDGEWISE THERAPEUTICS INC.
The fund managers got completely rid off GLOBUS MED INC (GMED), TENET HEALTHCARE CORP (THC) and EXACT SCIENCES CORP (EXAS) stocks. They significantly reduced their stock positions in ORUKA THERAPEUTICS INC, CASTLE BIOSCIENCES INC (CSTL) and XENCOR INC (XNCR). BRAIDWELL LP opened new stock positions in KODIAK SCIENCES INC (KOD), CENTESSA PHARMACEUTICALS PLC (CNTA) and BRIGHTSPRING HEALTH SVCS INC. The fund showed a lot of confidence in some stocks as they added substantially to FULCRUM THERAPEUTICS INC (FULC), SURROZEN INC (SRZN) and CELLDEX THERAPEUTICS INC NEW (CLDX).
BRAIDWELL LP Annual Return Estimates Vs S&P 500
Our best estimate is that BRAIDWELL LP made a return of 11.18% in the last quarter. In trailing 12 months, it's portfolio return was 5.32%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| kodiak sciences inc | 57,955,200 |
| centessa pharmaceuticals plc | 54,729,900 |
| brightspring health svcs inc | 44,782,200 |
| nurix therapeutics inc | 41,427,900 |
| illumina inc | 35,370,300 |
| mbx biosciences inc | 32,126,600 |
| rapt therapeutics inc | 31,488,700 |
| natera inc | 25,543,500 |
New stocks bought by BRAIDWELL LP
Additions
| Ticker | % Inc. |
|---|---|
| fulcrum therapeutics inc | 1,294 |
| surrozen inc | 235 |
| celldex therapeutics inc new | 214 |
| neogenomics inc | 161 |
| vera therapeutics inc | 66.00 |
| kymera therapeutics inc | 64.17 |
| dianthus therapeutics inc | 52.56 |
| hinge health inc | 43.29 |
Additions to existing portfolio by BRAIDWELL LP
Reductions
| Ticker | % Reduced |
|---|---|
| oruka therapeutics inc | -93.87 |
| castle biosciences inc | -78.46 |
| xencor inc | -63.16 |
| danaher corporation | -61.78 |
| krystal biotech inc | -61.16 |
| apogee therapeutics inc | -60.03 |
| argenx se | -59.25 |
| repligen corp | -58.2 |
BRAIDWELL LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| novocure ltd | -210,043,000 |
| karyopharm therapeutics inc | -34,955,500 |
| dexcom inc | -13,408,900 |
| immunocore hldgs plc | -6,188,220 |
| replimune group inc | -11,522,900 |
| day one biopharmaceuticals i | -15,380,300 |
| alphatec hldgs inc | -22,022,300 |
| sarepta therapeutics inc | -16,034,600 |
BRAIDWELL LP got rid off the above stocks
Sector Distribution
BRAIDWELL LP has about 72.8% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 72.8 |
| Others | 27.2 |
Market Cap. Distribution
BRAIDWELL LP has about 18.6% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- UNALLOCATED
- LARGE-CAP
- SMALL-CAP
- MICRO-CAP
| Category | % |
|---|---|
| MID-CAP | 34 |
| UNALLOCATED | 27.2 |
| LARGE-CAP | 18.6 |
| SMALL-CAP | 18.1 |
| MICRO-CAP | 2.1 |
Stocks belong to which Index?
About 50.2% of the stocks held by BRAIDWELL LP either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
- S&P 500
| Index | % |
|---|---|
| Others | 49.9 |
| RUSSELL 2000 | 39.4 |
| S&P 500 | 10.8 |
BRAIDWELL LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BRAIDWELL LP
BRAIDWELL LP has 68 stocks in it's portfolio. About 31.1% of the portfolio is in top 10 stocks. SLNO proved to be the most loss making stock for the portfolio. EWTX was the most profitable stock for BRAIDWELL LP last quarter.
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 1.74 | 2,032,020 | 54,275,300 | reduced | -14.57 | ||
| ADPT | adaptive biotechnologies cor | 0.16 | 311,991 | 5,066,730 | reduced | -57.61 | ||
| AGLE | spyre therapeutics inc | 1.71 | 1,634,620 | 53,550,000 | reduced | -36.6 | ||
| AKRO | akero therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALGN | align technology inc | 1.90 | 381,004 | 59,493,800 | reduced | -7.00 | ||
| AMLX | amylyx pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARGX | argenx se | 0.83 | 31,007 | 26,075,300 | reduced | -59.25 | ||
| ATEC | alphatec hldgs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BIIB | biogen inc | 0.65 | 115,700 | 20,362,000 | new | |||
| BMRN | biomarin pharmaceutical inc | 1.14 | 601,520 | 35,748,300 | added | 13.92 | ||
| CDNA | caredx inc | 0.96 | 1,585,220 | 29,865,500 | reduced | -27.38 | ||
| CLDX | celldex therapeutics inc new | 1.61 | 1,858,110 | 50,466,200 | added | 214 | ||
| CMPX | compass therapeutics inc | 0.48 | 2,786,780 | 14,965,000 | new | |||
| CNTA | centessa pharmaceuticals plc | 1.75 | 2,188,320 | 54,729,900 | new | |||
| CSTL | castle biosciences inc | 0.22 | 177,183 | 6,892,420 | reduced | -78.46 | ||
| CVS | cvs health corp | 1.43 | 564,200 | 44,774,900 | added | 28.64 | ||
| DAWN | day one biopharmaceuticals i | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DHR | danaher corporation | 0.87 | 118,227 | 27,064,500 | reduced | -61.78 | ||
| DRUG | bright minds biosciences inc | 0.81 | 324,358 | 25,312,900 | added | 6.81 | ||
| DXCM | dexcom inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||